For GCG analogs, prolonged cAMP signaling was seen with agonists displaying reduced β-arrestin-2 recruitment, but this did not translate to increases in downstream responses linked to hyperglycemia in the models tested. The gene discussed is GCG; the disease is Hyperglycemia.